| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Nathan G. Brower | EVP General Counsel | 2026-05-21 | 12,015 | $21.84 | $262.41kSell |
| Kevin Gregory Fuller | Global Chief Marketing Officer | 2026-05-05 | 573 | $25.92 | $14.85kSell |
| Bryant J. Yates | EVP President Europe | 2026-05-05 | 784 | $25.92 | $20.32kSell |
| Bryant J. Yates | EVP President Europe | 2026-05-05 | 707 | $25.92 | $18.32kSell |
| Kenneth G. Romanzi | Chief Executive Officer | 2026-05-05 | 5,753 | $25.92 | $149.09kSell |
| Daniel C. Norman | EVP President Asia | 2026-05-05 | 613 | $25.92 | $15.89kSell |
| Daniel C. Norman | EVP President Asia | 2026-05-05 | 784 | $25.92 | $20.32kSell |
| Daniel C. Norman | EVP President Asia | 2026-05-05 | 707 | $25.92 | $18.32kSell |
| Jonathan David Lanoy | SVP Chief Accounting Officer | 2026-05-05 | 327 | $25.92 | $8.47kSell |
| Jonathan David Lanoy | SVP Chief Accounting Officer | 2026-05-05 | 452 | $25.92 | $11.71kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Willem Mesdag | 99.41% | 17,481,976 | $382.16M | Insider |
| Eugene L. Hughes | 29.48% | 5,184,268 | $113.33M | Insider |
| Pauline Hughes | 28.24% | 4,966,513 | $108.57M | Insider |
| Jeffrey D. Watkins | 21.47% | 3,775,681 | $82.54M | Insider |
| Delta Partners LP | 18.07% | 3,178,004 | $69.47M | Insider |
| Shanghai Fosun Pharmaceutical Group Co Ltd | 16.60% | 2,918,774 | $63.80M | Insider |
| Wynnefield Partners Small Cap Value LP | 16.50% | 2,902,245 | $63.44M | Insider |
| Fosun Pharma Usa Inc | 16.23% | 2,854,607 | $62.40M | Insider |
| Wynnefield Capital Inc | 14.07% | 2,473,686 | $54.07M | Institution |
| Kristine F. Hughes | 10.95% | 1,925,963 | $42.10M | Insider |